Medication Underuse Headache: A Hidden Trigger for Migraine Chronification

Medication underuse headache (MUH), a newly recognized concept, is garnering attention in the medical community. MUH signifies the occurrence of headaches despite inadequate or delayed treatment of migraine attacks. It’s not merely a headache subtype, but a warning sign indicating a potential progression towards medication overuse headache (MOH).

The Connection Between MUH & MOH

“Medication underuse headache is the cause of medication overuse headache,” explains Dr. Alan M. Rapoport, clinical professor of neurology at the University of California, Los Angeles David Geffen School of Medicine. “It is very important that we teach doctors and patients about medication underuse headache so we can prevent medication overuse headache. Once medication overuse headache begins, it is hard to treat.”

Road to Chronification

While the exact risk factors for migraine chronification remain unclear, RApoport highlights MOH, increased migraine frequency, obesity, and potentially mental health conditions like depression and anxiety as key triggers. Effective acute treatment aims to halt the transition from peripheral to central nervous system sensitization, fully resolving migraine pain, disability, and the likelihood of recurrence.

Combatting Inadequate Migraine Treatment

Several factors can contribute to inadequate migraine treatment:

• Physicians prescribing the wrong medication or dosages, sometimes opting for lower doses than recommended.
• Patients delaying medication intake, often waiting until migraine symptoms are more severe.

Dr. Rapoport emphasizes the importance of prompt treatment. “The right time to start acute treatment is at the very start of a migraine attack,” or within 90 minutes of symptom onset. ” he says. “As soon as the patient starts to feel nausea, light sensitivity, or the pain is beginning and feels to the patient that it will be a migraine, that’s the time to take the medication.”

Underutilization of Preventive Medications

Research suggests underprescribing and underutilization of migraine preventive medications are widespread. A 2007 study published in Neurology found that only 12.4% of eligible patients were on migraine prevention medications, despite 38% being candidates. Furthermore, a 2015 Cephalalgia paper showed that only 17-20% of patients remained on traditional oral migraine preventatives after 12 months.

Dr. Rapoport advocates for proactive use of preventive medications. “If a patient has four severe headache attacks a month,” he advises, “they should be on preventive medication.”

Overcoming Barriers to MUH Recognition

The biggest hurdle to wider acceptance of the MUH concept is lack of awareness among physicians, according to Dr. Rapoport. He believes that open dialogues about best clinical practices and further research will ultimately lead to improved understanding and management of MUH.

Want to learn more about medication underuse headache and its impact on migraine management?

Talk to your healthcare provider about your migraine experiences and potential coping strategies.